Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Robust continuous in vitro culture of the Plasmodium cynomolgi erythrocytic stages.

Chua ACY, Ong JJY, Malleret B, Suwanarusk R, Kosaisavee V, Zeeman AM, Cooper CA, Tan KSW, Zhang R, Tan BH, Abas SN, Yip A, Elliot A, Joyner CJ, Cho JS, Breyer K, Baran S, Lange A, Maher SP, Nosten F, Bodenreider C, Yeung BKS, Mazier D, Galinski MR, Dereuddre-Bosquet N, Le Grand R, Kocken CHM, Rénia L, Kyle DE, Diagana TT, Snounou G, Russell B, Bifani P.

Nat Commun. 2019 Aug 12;10(1):3635. doi: 10.1038/s41467-019-11332-4.

2.

Colonization and growth of dehalorespiring biofilms on carbonaceous sorptive amendments.

Capozzi SL, Bodenreider C, Prieto A, Payne RB, Sowers KR, Kjellerup BV.

Biofouling. 2019 Jan;35(1):50-58. doi: 10.1080/08927014.2018.1563892. Epub 2019 Feb 21.

PMID:
30786761
3.

Utilization of the Maryland Environmental Justice Screening Tool: A Bladensburg, Maryland Case Study.

Driver A, Mehdizadeh C, Bara-Garcia S, Bodenreider C, Lewis J, Wilson S.

Int J Environ Res Public Health. 2019 Jan 26;16(3). pii: E348. doi: 10.3390/ijerph16030348.

4.

A Cryptosporidium PI(4)K inhibitor is a drug candidate for cryptosporidiosis.

Manjunatha UH, Vinayak S, Zambriski JA, Chao AT, Sy T, Noble CG, Bonamy GMC, Kondreddi RR, Zou B, Gedeck P, Brooks CF, Herbert GT, Sateriale A, Tandel J, Noh S, Lakshminarayana SB, Lim SH, Goodman LB, Bodenreider C, Feng G, Zhang L, Blasco F, Wagner J, Leong FJ, Striepen B, Diagana TT.

Nature. 2017 Jun 15;546(7658):376-380. doi: 10.1038/nature22337. Epub 2017 May 31.

5.

The Plasmodium PI(4)K inhibitor KDU691 selectively inhibits dihydroartemisinin-pretreated Plasmodium falciparum ring-stage parasites.

Dembele L, Ang X, Chavchich M, Bonamy GMC, Selva JJ, Lim MY, Bodenreider C, Yeung BKS, Nosten F, Russell BM, Edstein MD, Straimer J, Fidock DA, Diagana TT, Bifani P.

Sci Rep. 2017 May 24;7(1):2325. doi: 10.1038/s41598-017-02440-6.

6.

Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase.

Paquet T, Le Manach C, Cabrera DG, Younis Y, Henrich PP, Abraham TS, Lee MCS, Basak R, Ghidelli-Disse S, Lafuente-Monasterio MJ, Bantscheff M, Ruecker A, Blagborough AM, Zakutansky SE, Zeeman AM, White KL, Shackleford DM, Mannila J, Morizzi J, Scheurer C, Angulo-Barturen I, Martínez MS, Ferrer S, Sanz LM, Gamo FJ, Reader J, Botha M, Dechering KJ, Sauerwein RW, Tungtaeng A, Vanachayangkul P, Lim CS, Burrows J, Witty MJ, Marsh KC, Bodenreider C, Rochford R, Solapure SM, Jiménez-Díaz MB, Wittlin S, Charman SA, Donini C, Campo B, Birkholtz LM, Hanson KK, Drewes G, Kocken CHM, Delves MJ, Leroy D, Fidock DA, Waterson D, Street LJ, Chibale K.

Sci Transl Med. 2017 Apr 26;9(387). pii: eaad9735. doi: 10.1126/scitranslmed.aad9735.

7.

PI4 Kinase Is a Prophylactic but Not Radical Curative Target in Plasmodium vivax-Type Malaria Parasites.

Zeeman AM, Lakshminarayana SB, van der Werff N, Klooster EJ, Voorberg-van der Wel A, Kondreddi RR, Bodenreider C, Simon O, Sauerwein R, Yeung BK, Diagana TT, Kocken CH.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2858-63. doi: 10.1128/AAC.03080-15. Print 2016 May.

8.

Drug discovery for the developing world: progress at the Novartis Institute for Tropical Diseases.

Jones CL, Yeung BK, Manjunatha U, Shi PY, Bodenreider C, Diagana TT.

Nat Rev Drug Discov. 2015 Jun;14(6):442-4. doi: 10.1038/nrd4001-c1. No abstract available.

PMID:
26027536
9.

Lead optimization of imidazopyrazines: a new class of antimalarial with activity on Plasmodium liver stages.

Zou B, Nagle A, Chatterjee AK, Leong SY, Tan LJ, Sim WL, Mishra P, Guntapalli P, Tully DC, Lakshminarayana SB, Lim CS, Tan YC, Abas SN, Bodenreider C, Kuhen KL, Gagaring K, Borboa R, Chang J, Li C, Hollenbeck T, Tuntland T, Zeeman AM, Kocken CH, McNamara C, Kato N, Winzeler EA, Yeung BK, Diagana TT, Smith PW, Roland J.

ACS Med Chem Lett. 2014 Jul 6;5(8):947-50. doi: 10.1021/ml500244m. eCollection 2014 Aug 14.

10.

Targeting Plasmodium PI(4)K to eliminate malaria.

McNamara CW, Lee MC, Lim CS, Lim SH, Roland J, Simon O, Yeung BK, Chatterjee AK, McCormack SL, Manary MJ, Zeeman AM, Dechering KJ, Kumar TS, Henrich PP, Gagaring K, Ibanez M, Kato N, Kuhen KL, Fischli C, Nagle A, Rottmann M, Plouffe DM, Bursulaya B, Meister S, Rameh L, Trappe J, Haasen D, Timmerman M, Sauerwein RW, Suwanarusk R, Russell B, Renia L, Nosten F, Tully DC, Kocken CH, Glynne RJ, Bodenreider C, Fidock DA, Diagana TT, Winzeler EA.

Nature. 2013 Dec 12;504(7479):248-253. doi: 10.1038/nature12782. Epub 2013 Nov 27.

11.

Detection and quantification of flavivirus NS5 methyl-transferase activities.

Lim SP, Bodenreider C, Shi PY.

Methods Mol Biol. 2013;1030:249-68. doi: 10.1007/978-1-62703-484-5_20.

PMID:
23821274
12.

Selective and specific inhibition of the plasmodium falciparum lysyl-tRNA synthetase by the fungal secondary metabolite cladosporin.

Hoepfner D, McNamara CW, Lim CS, Studer C, Riedl R, Aust T, McCormack SL, Plouffe DM, Meister S, Schuierer S, Plikat U, Hartmann N, Staedtler F, Cotesta S, Schmitt EK, Petersen F, Supek F, Glynne RJ, Tallarico JA, Porter JA, Fishman MC, Bodenreider C, Diagana TT, Movva NR, Winzeler EA.

Cell Host Microbe. 2012 Jun 14;11(6):654-63. doi: 10.1016/j.chom.2012.04.015.

13.

Small molecule inhibitors that selectively block dengue virus methyltransferase.

Lim SP, Sonntag LS, Noble C, Nilar SH, Ng RH, Zou G, Monaghan P, Chung KY, Dong H, Liu B, Bodenreider C, Lee G, Ding M, Chan WL, Wang G, Jian YL, Chao AT, Lescar J, Yin Z, Vedananda TR, Keller TH, Shi PY.

J Biol Chem. 2011 Feb 25;286(8):6233-40. doi: 10.1074/jbc.M110.179184. Epub 2010 Dec 8.

14.

Crystal structure of the dengue virus methyltransferase bound to a 5'-capped octameric RNA.

Yap LJ, Luo D, Chung KY, Lim SP, Bodenreider C, Noble C, Shi PY, Lescar J.

PLoS One. 2010 Sep 17;5(9). pii: e12836. doi: 10.1371/journal.pone.0012836.

15.

A fluorescence quenching assay to discriminate between specific and nonspecific inhibitors of dengue virus protease.

Bodenreider C, Beer D, Keller TH, Sonntag S, Wen D, Yap L, Yau YH, Shochat SG, Huang D, Zhou T, Caflisch A, Su XC, Ozawa K, Otting G, Vasudevan SG, Lescar J, Lim SP.

Anal Biochem. 2009 Dec 15;395(2):195-204. doi: 10.1016/j.ab.2009.08.013. Epub 2009 Aug 13.

PMID:
19682971
16.

Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics.

Ekonomiuk D, Su XC, Ozawa K, Bodenreider C, Lim SP, Otting G, Huang D, Caflisch A.

J Med Chem. 2009 Aug 13;52(15):4860-8. doi: 10.1021/jm900448m.

PMID:
19572550
17.

Discovery of a non-peptidic inhibitor of west nile virus NS3 protease by high-throughput docking.

Ekonomiuk D, Su XC, Ozawa K, Bodenreider C, Lim SP, Yin Z, Keller TH, Beer D, Patel V, Otting G, Caflisch A, Huang D.

PLoS Negl Trop Dis. 2009;3(1):e356. doi: 10.1371/journal.pntd.0000356. Epub 2009 Jan 13.

18.

Structural and functional characterization of an essential RTX subdomain of Bordetella pertussis adenylate cyclase toxin.

Bauche C, Chenal A, Knapp O, Bodenreider C, Benz R, Chaffotte A, Ladant D.

J Biol Chem. 2006 Jun 23;281(25):16914-26. Epub 2006 Apr 20.

19.

Interpretation of protein folding psi values.

Bodenreider C, Kiefhaber T.

J Mol Biol. 2005 Aug 12;351(2):393-401.

PMID:
16005895
20.

Antifolding activity of the SecB chaperone is essential for secretion of HasA, a quickly folding ABC pathway substrate.

Wolff N, Sapriel G, Bodenreider C, Chaffotte A, Delepelaire P.

J Biol Chem. 2003 Oct 3;278(40):38247-53. Epub 2003 Jun 26.

21.

Kinetic analysis of R67 dihydrofolate reductase folding: from the unfolded monomer to the native tetramer.

Bodenreider C, Kellershohn N, Goldberg ME, Méjean A.

Biochemistry. 2002 Dec 17;41(50):14988-99.

PMID:
12475248
22.

Kinetic characterization of the pH-dependent oligomerization of R67 dihydrofolate reductase.

Méjean A, Bodenreider C, Schuerer K, Goldberg ME.

Biochemistry. 2001 Jul 10;40(27):8169-79.

PMID:
11434787

Supplemental Content

Loading ...
Support Center